Dai, Jing-Ying <br/><br/>
[Effects of Tyrosine Kinase Inhibitors on the Th1 and Treg Cells of CML Patients].  [electronic resource] 

 -  Zhongguo shi yan xue ye xue za zhi  Feb 2019 
 - 25-32 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1009-2137 
<br/><br/><label>Standard No.: </label>10.7534/j.issn.1009-2137.2019.01.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Dasatinib<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive<br/>Protein Kinase Inhibitors<br/>Protein-Tyrosine Kinases<br/>T-Lymphocytes, Regulatory<br/>Th1 Cells<br/>Treatment Outcome